Frede Olesen

Size: px
Start display at page:

Download "Frede Olesen"

Transcription

1 , Professor, MD, DrMedSc, FRCGP (hon.) The Research Unit for General Practice Aarhus University, Denmark Former chairman for the Danish Cancer Society

2 2004: Due time suspicion of cancer = the patient must wait for service from NHS A large number of supportive letters from doctors and lay people - this is a national problem, that must be dealt with

3 Milestones in early diagnosis - the Aarhus statement Total interval Patient interval Doctor interval System interval Primary care interval Secondary care interval Diagnostic interval Treatment interval First symptom First presentation / clinical appearance First investigation, primary care responsible for the patient First referral to secondary care/transfer of responsibility First specialist visit Diagnosis Treatment start Source: Weller D et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. BJC 2012;106:1262 7

4 The 3 cancer plans in Denmark National Cancer Plan I: Hospitals/medicine Radiotherapy equipment 2-week waiting time guarantee from diagnosis to treatment National Cancer Plan II: Hospitals/medicine Screening Case management Fast track referral Palliative treatment Cancer Patient Pathways (CPPs) National Cancer Plan III: Hospitals/medicine Screening Diagnostic centres Health education and promotion National training programme for GPs on diagnosing cancer Public Cancer Awareness campaign Policies: Research: Comparison of Nordic cancer registries Studies quantifying delay among Danish cancer patients Studies exploring reasons for and impact of delay New comparison of Nordic cancer registries Tørring ML. The Danish National Board of Health 200, 2005, 2010; Olesen 2009; Vrangbæk 2010; Søgaard 2011

5 The diagnostic process >15% of adults have alarm symptoms every year The ocean of symptoms And ALL the other symptoms In 6% of consultations, the GP suspects serious disease incl. cancer (1-2 per day) Attend the doctor 50% referred, primarily to imaging 50% wait and see Referred to secondary care 5% have cancer (1 per month) Cancer

6 Lung cancer - delay in primary care Delay in primary health care Delay in days Delay in primary health care 25% 50% 75% Delay in days % 50% 75% Patients Patients False negative x-ray Weak and unspecific symptoms Marianne Bjerager. phd afhandling Forskningsenheden for Almen Praksis, Aarhus Universitet, Delay in diagnosis and treatment of lung cancer

7 Time from first symptom until treatment Olesen, Hansen, Vedsted. British Journal of Cancer. 2009;101:S5 S8. - Hansen, Vedsted, Olesen et al. BMC Health Serv Res. 2011;11:284.

8 Total interval broken up - Olesen, Hansen, Vedsted. British Journal of Cancer. 2009;101:S5 S8. - Hansen, Vedsted, Olesen et al. BMC Health Serv Res. 2011;11:284.

9 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim System delay prim. c. GP Lægedelay Systemdelay Sec System delay sec. c.

10 Positive predictive value of alarm symtoms in GP - a GP must investigate or refer between 13 and 50 patients to find one cancer in patients with alarm symptoms Blood in the urine Difficulty in swallowing Blood in sputum Men Women N Cancer PPV 3 year Cancer PPV 3year ,4% 162 3,4% ,7% 81 2,4% ,5% 81 4,3% Blood in stools ,4% 154 2,0% Jones R et al. BMJ 2007;334;1040

11 Adverse effect of the gatekeeper system? - Gatekeeper systems: the systems with long waits and often double gatekeeping with poor access to diagnostic services (scans, endoscopies and diagnostic imaging) Relative one-year survival (%) Countries Median (%) p-value Gatekeeper No Yes List system No Yes First point of contact Always Depends No Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper principles? BJGP 2011

12 E.g. Presenting symptoms in 1900 consecutive newly diagnosed cancer patients Nielsen, Hansen, Vedsted. Ugeskr Læger. 2010;172:

13 Delay in the diagnostic process increases mortality - or the story about flaws in previous analytical thinking Thesis Marie Louise Tørring 13

14 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim System delay prim. c. GP Lægedelay Systemdelay Sec System delay sec. c.

15 The GPs see three types of symptoms! Symptom type % of cancer patients Alarm symptom 50 Serious, non-specific 20 Common 30 Jensen H, et al. BMC Cancer 2014;14:636 Nielsen T, el al. Ugeskr Læger. 2010;172:

16 Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society : Improved acces to relevant diagnostic investigations without waits when required by the front line GPs (What we now tends to call the yes/no concept) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred by the GP with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility. Please help my patient 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy FROM 2007 MASSIVE POLITICAL AND MANAGERIAL FOCUS ON CANCER AS AN ACUTE DISEASE

17 The diagnostic centre

18 But what about the simple problem..?

19 Symptoms in general practice a continuum Trivial Low-but-not-no-risk Serious Refer Green: Managed in practice perhaps a follow-up Red: Refer to relevant investigation! Grey: Is it something? Should/can I refer? Serious yes or no?

20 Change the GPs or change the system? Increase the GPs awareness Educate GPs in how to use the system correctly Develop indicators of GP performance But what if it is the health system that is functioning poorly?

21 GP and hospitals collaboration on diagnosis The 3-legged strategy a ship with 3 masts

22 Where are we now The fast track with diagnostic packages are working (well?) The concept with diagnostic centres are implemented in all regions and is about to be understood by clinicians and administrators they develop in two directions: a clean diagnostic center for the difficult diagnosis a two legged centre: the difficult the yes/no approach Government now go for improved yes/no access to hospital investigations from GP incl. technology improvement.

23 What is the yes/no concept? Trivial Low-but-not-no-risk Serious Refer When a GP has a grey patient: he needs a short answer should I think of serious disease. Yes or no The tool to give the answer is often a simple investigation. The government demands that hospitals give GPs easy and quick access to these investigations without waits the hospital as a diagnostic service provider to GP s patients

24 Direct access to investigations Implemented as No-Yes-Clinics (NYC) GPs have direct access to expedited investigations Ultrasonic investigation of abdomen, pelvis, CT, endoscopy etc. The GP is fully responsible No record, history taking etc. at clinic only a No or a Yes!

25 The Danish (and British?) mistake We believed far too much in screening max 10-15% of all cancers We believed too much in a fast track approach We started with a cancer diagnosis and not a symptom in our thinking it is changing within the last year We did not know the waiting time paradox and its explanations We did not listen to GPs and the way they meet patients We started implementation of the 3 legged strategy with fast tracks for a suspected cancer we should have started with yes/no It took long time before diagnostic centres were understood We are about to understand the yes/no concept

26 Increase in 1-year relative survival for WOMEN All cancers except skin and breast Engholm G, et al. Danish Cancer Society. Unpublished

27 Increase in 1-year relative survival for MEN All cancers except skin and prostate Engholm G, et al. Danish Cancer Society. Unpublished

28 This summer a new government. - and the election campain had health care as a main componenet - a patient has the right to have a complete diagnostic work up within 30 days - a patient with a diagnosis has the right to be treated within 30 days - we need a 4th cancer plan to ensure that we can cope with demand

29 The cancer-journey - The Ca-Pri vision for a research agenda and for a good life after cancer Dying Terminal Support of relatives Recurrence of disease Rehabilitation Treatment Final diagnostics Primary diagnostics incl. waiting times Which symptoms are predictive of what? Perceived symptoms, iatrogenic threshold Screening Life style, health promotion, primary prevention Crisis Need for GP

30 Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society : Improved acces to relevant diagnostic investigations without waits when required by the front line GPs (What we now tends to call the yes/no concept) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred by the GP with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility. Please help my patient 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy FROM 2007 MASSIVE POLITICAL AND MANAGERIAL FOCUS ON CANCER AS AN ACUTE DISEASE

31 Center for Research in Cancer Diagnosis in Primary Care CaP The head of a research driven proces with a changed understanding of the diagnosis of cancer in GP

32

Frede Olesen. Frede Olesen

Frede Olesen. Frede Olesen Professor, DrMedSc, GP, FRCGP(hon.) The Research Unit for General Practice, Aarhus University Chairman of the board of The Danish Cancer Society FO@alm.au.dk Denmark - City of Aarhus How to get be)er

More information

Good clinicians in supportive healthcare systems

Good clinicians in supportive healthcare systems Good clinicians in supportive healthcare systems the Danish three-legged strategy for cancer diagnosis 3rd NAEDI Research Conference London 2015 Peter Vedsted Professor Research Centre for Cancer Diagnosis

More information

Danish Three-Legged Strategy for Early Diagnosis - an integrating approach

Danish Three-Legged Strategy for Early Diagnosis - an integrating approach Danish Three-Legged Strategy for Early Diagnosis - an integrating approach Peter Vedsted Professor, Director Lower 1-year survival in Denmark Local stage for breast or lung cancer % lung cancer in local

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging Multidisciplinary Diagnostic Centre (MDC) models and design principles ACE Wave 2: exploring the concept of MDC-based pathways ACE Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging multidisciplinary diagnostic centre (MDC) models and design principles ACE wave 2: exploring the concept of MDC-based pathways ACE Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging multidisciplinary diagnostic centre (MDC) models and design principles ACE wave 2: exploring the concept of MDC-based pathways Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

The primary care perspective Dr Richard Roope

The primary care perspective Dr Richard Roope The primary care perspective Dr Richard Roope RCGP & CRUK Clinical Lead for Cancer CRUK Senior Clinical Advisor (Prevention and Early Diagnosis) The challenges within primary care Cancer in the primary

More information

OCCG Board Meeting. Oxfordshire Clinical Commissioning Group. Date of Meeting: 30 November 2017 Paper No: 17/80

OCCG Board Meeting. Oxfordshire Clinical Commissioning Group. Date of Meeting: 30 November 2017 Paper No: 17/80 OCCG Board Meeting Oxfordshire Clinical Commissioning Group Date of Meeting: 30 November 2017 Paper No: 17/80 Title of Paper: SCAN Pathway Project Update Paper is for: (please delete tick as appropriate)

More information

From symptom to treatment International research centre for the diagnosis of cancer

From symptom to treatment International research centre for the diagnosis of cancer From symptom to treatment International research centre for the diagnosis of cancer Midway report October 2012 The Danish Cancer Society and the Novo Nordisk Foundation Research Centre for Cancer Diagnosis

More information

VARIATION IN HEALTH CARE AND OUTCOME Principles and examples

VARIATION IN HEALTH CARE AND OUTCOME Principles and examples VARIATION IN HEALTH CARE AND OUTCOME Principles and examples Symposium September 2014 Peter Vedsted Peter Hjertholm The Research Unit for General Practice Research Centre for Cancer Diagnosis in Primary

More information

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center Acta Orthopaedica 2014; 85 (6): x x 1 Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center Heidi B Dyrop 1,4, Peter Vedsted 2, Akmal Safwat 3,4, Katja Maretty-Nielsen

More information

THE INTERNATIONAL CANCER BENCHMARKING PARTNERSHIP: GLOBAL LEARNING FROM OUR RESULTS Harpal Kumar, Chief Executive, Cancer Research UK UICC World

THE INTERNATIONAL CANCER BENCHMARKING PARTNERSHIP: GLOBAL LEARNING FROM OUR RESULTS Harpal Kumar, Chief Executive, Cancer Research UK UICC World THE INTERNATIONAL CANCER BENCHMARKING PARTNERSHIP: GLOBAL LEARNING FROM OUR RESULTS Harpal Kumar, Chief Executive, Cancer Research UK UICC World Cancer Congress, 5 December 2014 Melbourne, Australia Outline

More information

DIAGNOSIS, CLINICAL ASSESSMENT AND PROGNOSIS IN

DIAGNOSIS, CLINICAL ASSESSMENT AND PROGNOSIS IN DIAGNOSIS, CLINICAL ASSESSMENT AND PROGNOSIS IN PATIENTS WITH NON SPECIFIC SERIOUS SYMPTOMS PhD dissertation Esben Næser Faculty of Health Aarhus University 2017 Diagnosis, clinical assessment and prognosis

More information

Experiences from building up the Danish National Clinical Cancer Database

Experiences from building up the Danish National Clinical Cancer Database Experiences from building up the Danish National Clinical Cancer Database Anders Green, Professor and Consultant Epidemiologist, MD, DrMedSci Odense University Hospital and University of Southern Denmark

More information

NICE Quality Standards and COF

NICE Quality Standards and COF NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards

More information

In this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care

In this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care Newsletter Summer 2016 In this edition: How Primary Care can help earlier diagnosis Improving communication between Primary & Secondary Care A new approach to longer term care How primary care is adapting

More information

Improving services for upper GI (OG) cancer Application template (Version 2)

Improving services for upper GI (OG) cancer Application template (Version 2) Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper

More information

DENOMINATOR: Patients undergoing endovascular lower extremity revascularization

DENOMINATOR: Patients undergoing endovascular lower extremity revascularization Measure #437: Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,

More information

Single Suspected Cancer Pathway Definitions pathway start date

Single Suspected Cancer Pathway Definitions pathway start date Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document

More information

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed

More information

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two

More information

Identifying distinguishing features of the MDC model within the five ACE projects

Identifying distinguishing features of the MDC model within the five ACE projects Identifying distinguishing features of the MDC model within the five ACE projects Context: The ACE Programme (Wave 2) has been working with five projects across England to trial and evaluate the concept

More information

GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION

GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION Bohumil Seifert Dpt. Of General Practice 1st Faculty of Medicine Charles University in Prague May, 29, 2015 European Colorectal Cancer Days, Brno

More information

Mette Bach Larsen 1,2,3*, Rikke Pilegaard Hansen 1,3, Dorte Gilså Hansen 4, Frede Olesen 1,3 and Peter Vedsted 1,3

Mette Bach Larsen 1,2,3*, Rikke Pilegaard Hansen 1,3, Dorte Gilså Hansen 4, Frede Olesen 1,3 and Peter Vedsted 1,3 Larsen et al. BMC Health Services Research 213, 13:348 RESEARCH ARTICLE Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative

More information

Suspected CANcer (SCAN) Pathway Information for patients

Suspected CANcer (SCAN) Pathway Information for patients Suspected CANcer (SCAN) Pathway Information for patients page 2 Your GP has advised you may benefit from investigation via the SCAN pathway. The SCAN pathway is part of a national programme called ACE

More information

Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer

Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer NICaN Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer Timed schedules to enable the proactive management of the patient from point of receipt of referral to first definitive treatment

More information

Evaluation of Cancer Outcomes Barwon South West Registry

Evaluation of Cancer Outcomes Barwon South West Registry Evaluation of Cancer Outcomes Barwon South West Registry Data Request Form Applicant details Applicant name: Position: Email: Project start date: Date: Telephone: Project completion date: Project details

More information

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,

More information

Do rural cancer patients present later than those in the city?

Do rural cancer patients present later than those in the city? Do rural cancer patients present later than those in the city? Dr Katie Hoff ( M.B.B.S.) Acknowledgements: Prof. J. Emery, V. Gray, D. Howting September 2011 BACKGROUND Cancer is a leading causes of death

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #437: Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

National Cancer Programme. Work Plan 2014/15

National Cancer Programme. Work Plan 2014/15 National Cancer Programme Work Plan 2014/15 Citation: Ministry of Health. 2014. National Cancer Programme: Work Plan 2014/15. Wellington: Ministry of Health. Published in December 2014 by the Ministry

More information

Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective

Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective Housekeeping Toilets Fire alarm Tea and Coffee Wifi: MSE-meeting rooms Password: mselondon Twitter - #gettingitright

More information

Danish Cancer Society; PRO - Projects

Danish Cancer Society; PRO - Projects Danish Cancer Society; PRO - Projects PRO Cancer Patient Reports PROM projects (ongoing) Population-based: Lung cancer Clinical-based : o Lung cancer : Model 1 o Prostate cancer: Model 2 Adverse events:

More information

TRANSFORM CANCER SERVICES

TRANSFORM CANCER SERVICES WORKING TOGETHER to TRANSFORM CANCER SERVICES in SOUTH EAST WALES 1 Understanding the context Cancer survival rates are increasing. But the number of people getting cancer is increasing too. At Velindre

More information

With you for the journey

With you for the journey With you for the journey not just for the assessment With you every step of the way Score Score s Every journey begins with the first step The first movement FORWARD in the direction you want to travel

More information

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South

More information

CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)

CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and

More information

With you for the journey

With you for the journey With you for the journey not just for the assessment With you every step of the way Expert s Every journey begins with the first step The first movement FORWARD in the direction you want to travel Not

More information

We need to talk about Palliative Care. Pancreatic Cancer UK

We need to talk about Palliative Care. Pancreatic Cancer UK We need to talk about Palliative Care Pancreatic Cancer UK 1. Pancreatic Cancer UK welcomes the opportunity to respond to the Health and Sport Committee s inquiry on palliative care. About Pancreatic Cancer

More information

Cancer of Unknown Primary Service

Cancer of Unknown Primary Service Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT

More information

Improving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust

Improving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Improving Cancer Pathways Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Background Poor / inconsistent 62 day performance, across a number of specialities

More information

WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected

More information

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY

More information

Supporting people at higher risk of bowel cancer

Supporting people at higher risk of bowel cancer #never2young Never too young: Supporting people at higher risk of bowel cancer Campaign briefing Supporting people at higher risk of bowel cancer Bowel cancer is the second most common cause of cancer

More information

National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August

More information

Data & Definitions Frequently Asked Questions

Data & Definitions Frequently Asked Questions Cancer Waiting Times Data & Definitions Frequently sked uestions This document provides questions and answers on data and definitions for Cancer Waiting Times. Further information can be found in the Guidance

More information

Cancer in Elderly in Denmark

Cancer in Elderly in Denmark Cancer in Elderly in Denmark - Route to Diagnosis, Treatment and Prognosis Project proposal by: - Bolette Danckert (Danish Cancer Society) - Henry Jensen (Centre for Cancer Diagnosis in Primary Care, Aarhus)

More information

However, the time taken to reach the diagnosis is just as crucial for quality of care.

However, the time taken to reach the diagnosis is just as crucial for quality of care. Oxfordshire Clinical Commissioning Group Cancer referrals new lung pathway GPs are in the front line for referrals. The 2015 NICE cancer guidelines were altered to reduce the threshold for making referrals

More information

The role of risk tools in diagnosing cancer in primary care

The role of risk tools in diagnosing cancer in primary care Cancer Jon Emery Peggy Chiang The role of risk tools in diagnosing cancer in primary care Background Diagnosing cancer on the basis of a patient s symptoms and risk factors is a core role for general practice.

More information

Screening for non-communicable diseases: the intended benefits and the unintended harms

Screening for non-communicable diseases: the intended benefits and the unintended harms Screening for non-communicable diseases: the intended benefits and the unintended harms John Brodersen MD, GP, PhD, Professor Centre of Research & Education in General Practice, Department of Public Health

More information

1 Non-clinical interventions

1 Non-clinical interventions 1 Non-clinical interventions How effective and cost effective are non-clinical interventions to reduce the rate of suicide? Approximately 6,000 people take their own life each year in the UK. Many are

More information

Radiology. General radiology department. X-ray

Radiology. General radiology department. X-ray The radiology directorate provides a diagnostic, interventional and therapeutic service for its local population, and a tertiary service for the region. It also provides support to some national work such

More information

Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.

Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Document Title An Overview of Commissioning Living with and Beyond Cancer in Yorkshire and Humber Version number: 1 First

More information

Prostate cancer aggression test 'may avoid needless ops'

Prostate cancer aggression test 'may avoid needless ops' 5 November 2013 Last updated at 00:00 GMT Prostate cancer aggression test 'may avoid needless ops' By James Gallagher Health and science reporter, BBC News Prostate tumour: The challenge is spotting which

More information

The next paradigm in cancer diagnosis: introducing the CanTest Collaborative from the how to the who

The next paradigm in cancer diagnosis: introducing the CanTest Collaborative from the how to the who The next paradigm in cancer diagnosis: introducing the CanTest Collaborative from the how to the who Fiona Walter GP & NIHR Clinician Scientist University of Cambridge CR Early Diagnosis Research Conference

More information

Improving diagnostic pathways for patients with vague symptoms

Improving diagnostic pathways for patients with vague symptoms Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer

More information

Diagnostic Journeys in Myeloma (DJiM): Tania Seale PhD Student North Wales Centre for Primary Care Research

Diagnostic Journeys in Myeloma (DJiM): Tania Seale PhD Student North Wales Centre for Primary Care Research CANOLFAN GOGLEDD CYMRU AR GYFER YMCHWIL GOFAL CYCHWYNNOL NORTH WALES CENTRE FOR PRIMARY CARE RESEARCH Diagnostic Journeys in Myeloma (DJiM): Tania Seale PhD Student North Wales Centre for Primary Care

More information

Using patient data to improve. cancer waiting times. May 2018

Using patient data to improve. cancer waiting times. May 2018 Using patient data to improve cancer waiting times May 2018 Summary Background We used patient-level data from Hospital Episode Statistics (HES) for 2016/17 to carry out detailed analysis of what drives

More information

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some

More information

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. East Kent Hospitals University NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

ACE Programme: Proactive Approaches to People at High Risk of Lung Cancer

ACE Programme: Proactive Approaches to People at High Risk of Lung Cancer ACE Programme: Proactive Approaches to People at High Risk of Lung Cancer Introduction November 2016 Cluster Update The ACE Programme identified and then clustered six local projects that were aiming to

More information

2010 National Survey. University College London Hospitals NHS Foundation Trust

2010 National Survey. University College London Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

Action against Depression and Suicide Suicide Prevention Programmes: Integrating Implementation and Evaluation

Action against Depression and Suicide Suicide Prevention Programmes: Integrating Implementation and Evaluation Action against Depression and Suicide Suicide Prevention Programmes: Integrating Implementation and Evaluation Professor Ella Arensman National Suicide Research Foundation Department of Epidemiology and

More information

Developing Key Messages on Cancer for Commissioners

Developing Key Messages on Cancer for Commissioners Developing Key Messages on Cancer for Commissioners Overarching messages (1) 1. NCIN/NCAT working with local cancer networks are keen to support GP commissioners to: Save lives Improve patients quality

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan

More information

The Danish Palliative Care Trial (DanPaCT), a randomised trial of early palliative care in cancer. Results of the primary analysis

The Danish Palliative Care Trial (DanPaCT), a randomised trial of early palliative care in cancer. Results of the primary analysis The Danish Palliative Care Trial (DanPaCT), a randomised trial of early palliative care in cancer Results of the primary analysis Mogens Groenvold Head of Research Unit, Department of Palliative Medicine,

More information

Leslie Riley. Sarcoma Program AT SMILOW CANCER HOSPITAL

Leslie Riley. Sarcoma Program AT SMILOW CANCER HOSPITAL Leslie Riley Sarcoma Program AT SMILOW CANCER HOSPITAL The Sarcoma Program at Smilow Cancer Hospital is a multidisciplinary team of physicians specialized in the diagnosis, treatment, and care of patients

More information

The Single Cancer Pathway

The Single Cancer Pathway The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

Health Policy 120 (2016) Contents lists available at ScienceDirect. Health Policy

Health Policy 120 (2016) Contents lists available at ScienceDirect. Health Policy Health Policy 120 (2016) 1378 1382 Contents lists available at ScienceDirect Health Policy j ourna l ho me pa g e: www.elsevier.com/locate/healthpol Health Reform Monitor The 2015 National Cancer Program

More information

The effect of direct access to CT scan in early lung cancer detection: an unblinded, cluster-randomised trial

The effect of direct access to CT scan in early lung cancer detection: an unblinded, cluster-randomised trial Guldbrandt et al. BMC Cancer (2015) 15:934 DOI 10.1186/s12885-015-1941-2 RESEARCH ARTICLE The effect of direct access to CT scan in early lung cancer detection: an unblinded, cluster-randomised trial Louise

More information

The RAPID Programme Rapid Access to Pulmonary Investigation & Diagnosis

The RAPID Programme Rapid Access to Pulmonary Investigation & Diagnosis Patient Experience National Network Awards (PENNA) The RAPID Programme 2016-2019 Rapid Access to Pulmonary Investigation & Diagnosis Kath Hewitt Lead Clinical Nurse Specialist Ailsa Rowlands Programme

More information

North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network

North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network Introduction Cancer Incidence & Projected Trends National ISD reported that

More information

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC : THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University

More information

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey South Tees Hospitals NHS Foundation Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

Improving end of life care in dementia in acute care through collaborative working. Angela Moore Admiral Nurse

Improving end of life care in dementia in acute care through collaborative working. Angela Moore Admiral Nurse Improving end of life care in dementia in acute care through collaborative working Angela Moore Admiral Nurse Understand the interplay between national policy and professional guidance when providing end

More information

DCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018

DCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018 DCP Newsletter Issue 1 June 2018 Welcome Hello and a warm welcome to all of our readers of this first edition of the Dorset Cancer Partnership (DCP) newsletter. Each edition of this newsletter will provide

More information

Setting up an effective falls prevention assessment and intervention programme : Experiences in the Region Languedoc-Roussillon

Setting up an effective falls prevention assessment and intervention programme : Experiences in the Region Languedoc-Roussillon Falls prevention: Evidence into Practice European Seminar Glasgow, 19 November 2014 Setting up an effective falls prevention assessment and intervention programme : Experiences in the Region Languedoc-Roussillon

More information

Ca-PRI 5 th Annual Conference: June , Cleveland, Ohio, USA Learning from Our Differences

Ca-PRI 5 th Annual Conference: June , Cleveland, Ohio, USA Learning from Our Differences Ca-PRI 5 th Annual Conference: June 5-7 2012, Cleveland, Ohio, USA Learning from Our Differences (All sessions at the Cleveland Intercontinental Hotel unless otherwise specified) Tuesday June 5 th 13:30

More information

One Stop Prostate Biopsy Protocol Author Consultation Date Approved

One Stop Prostate Biopsy Protocol Author Consultation Date Approved One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer

More information

Indigestion (dyspepsia)

Indigestion (dyspepsia) Commissioning pathways Indigestion (dyspepsia) Supplementary information to be read in conjunction with the pathway Reference Supplementary Information 1.1 Symptom Description Annual incidence 40%. Prevalence

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

Table 1 Standards and items to set up a PCU: general requirements and critical mass

Table 1 Standards and items to set up a PCU: general requirements and critical mass Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site

More information

Enhancing the Quality of Heart Failure Care

Enhancing the Quality of Heart Failure Care Enhancing the Quality of Heart Failure Care 2 Enhancing the quality of Heart Failure care Kent Surrey Sussex Academic Health Science Network 3 Contents 2 Heart failure care in the UK: Case for change 3

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

The context and the doctor as a drug A renaissance for the personal doctor in clinical practice

The context and the doctor as a drug A renaissance for the personal doctor in clinical practice The context and the doctor as a drug A renaissance for the personal doctor in clinical practice, Professor, MD, GP, DrMedSci, FRCGP (hon.) The Research Unit for General Practice Aarhus University, Denmark

More information

St. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton

St. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton St. Joseph s Regional Thoracic Program Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton SJHH REGIONAL THORACIC PROGRAM Collaboration & Integration Thoracic Surgery - Malignant

More information

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation

More information

Variation in optimal pre-diagnostic pathway in lung cancer patients in 2013 & 2014 using cancer registrations and the diagnostic imaging dataset

Variation in optimal pre-diagnostic pathway in lung cancer patients in 2013 & 2014 using cancer registrations and the diagnostic imaging dataset Variation in optimal pre-diagnostic pathway in lung cancer patients in 2013 & 2014 using cancer registrations and the diagnostic imaging dataset Clare Pearson Senior Cancer Information Analyst, ACE Programme,

More information

The poor cancer patient - social inequality in outcomes after cancer

The poor cancer patient - social inequality in outcomes after cancer The poor cancer patient - social inequality in outcomes after cancer Susanne Dalton Senior Researcher, MD, PhD Survivorship Danish Cancer Society Research Center This talk 2 Social position and cancer

More information

Vacancy list Pathway Boards

Vacancy list Pathway Boards Vacancy list Pathway Boards The table below includes all the current vacancies for Pathway Boards. If you would like to apply to be a patient and carer representative on a Pathway Board, you need to have

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes Cancer and Data in the New NHS May 2011 Di Riley, Director Clinical Outcomes Overarching NHS context Financial constraints White Paper GP Commissioning/Commissioning Board Public Health England National

More information

South East Coast Operational Delivery Network. Critical Care Rehabilitation

South East Coast Operational Delivery Network. Critical Care Rehabilitation South East Coast Operational Delivery Networks Hosted by Medway Foundation Trust South East Coast Operational Delivery Network Background Critical Care Rehabilitation The optimisation of recovery from

More information